Form 8-K - Current report:
SEC Accession No. 0001564590-20-048502
Filing Date
2020-10-29
Accepted
2020-10-29 06:31:16
Documents
15
Period of Report
2020-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-8k_20201029.htm   iXBRL 8-K 44840
2 EX-99.1 d79548dex991.htm EX-99.1 836069
3 GRAPHIC g79548logo.jpg GRAPHIC 14875
4 GRAPHIC gspub3ibvtkt000001.jpg GRAPHIC 2130
  Complete submission text file 0001564590-20-048502.txt   1069548

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA idxx-20201029.xsd EX-101.SCH 5764
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20201029_lab.xml EX-101.LAB 18708
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20201029_pre.xml EX-101.PRE 11164
8 EXTRACTED XBRL INSTANCE DOCUMENT idxx-8k_20201029_htm.xml XML 3420
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 201270387
SIC: 2835 In Vitro & In Vivo Diagnostic Substances